All
New study verifies value of CSE - with or without dermoscopy
May 6th 2008Graz, Austria - Though complete skin examination (CSE) by dermoscopy takes longer to conduct than CSE alone when screening for skin cancer, physicians should consider three-minute screening for the disease with either method, according to the results of a study reported by MedScape Today.
Study links high IL-12 levels, increased melanoma mortality
May 6th 2008Houston - Data from a large cohort study shows that an elevated level of interleukin-12 is associated with a significantly increased mortality risk in patients with stage III melanoma with regional metastasis, according to MedPageToday.
Enbrel yields striking improvement in kids
May 1st 2008A phase 3 double-blind, placebo-controlled study shows remarkable efficacy of etanercept for treating pediatric psoriasis, bettering even those results observed in adults. The findings could help pave the way for Food and Drug Administration approval of the biologic, which could change the face of systemic treatment of psoriasis in children.
Psoriasis: New biologics coming closer to market
May 1st 2008Newer biologics to treat psoriasis are currently in late stages of development, and promising data from phase 2 and phase 3 clinical trials should give patients reason to hope. The biologics may be available as early as the end of 2008 or during 2009.
New actinic keratoses therapies take shape: Cosmetic component will always cloud reimbursement
May 1st 2008In the treatment of actinic keratoses, Peplin, a topical gel made from the sap of the Australian Euphorbia peplus, and cosmetic therapies show promise for preventing recurrences, but likely won't ever be front-line treatments. Meanwhile, the one treatment approved by the U.S. Food and Drug Administration treatment that also offers cosmetic benefits, ALA-PDT, comes with coding issues that some say make it difficult for doctors to obtain reasonable compensation.
Imiquimod has potential for treating Bowen's disease, possibly leishmaniasis
May 1st 2008New research indicates that topical imiquimod has potential for treating conditions ranging from Bowen's disease to leishmaniasis. Problems with inflammation and recurrences of conditions such as actinic keratosis, however, are still being investigated.
Antihistamine relieves atopic dermatitis itch
May 1st 2008Vapitadine (Barrier Therapeutics) is an investigational oral antihistamine that belongs to a new structural class of H1-selective, nonsedating agents. Results of a randomized, placebo-controlled clinical trial in adults with atopic dermatitis demonstrated its efficacy for relieving itch and added to an existing database showing vapitadine has an excellent safety profile.
Photodynamic therapy for nonmelanoma skin cancers: Nonsurgical route is safe, effective
May 1st 2008Photodynamic therapy is a safe, effective treatment for nonmelanoma skin cancers, according to an expert. Though the therapy is not yet approved for the treatment of skin cancer in the U.S., It has been accepted, approved, and recommended as a potential first-line of therapy for superficial basal cell carcinomas, and some superficial squamous cell carcinomas outside the U.S.
Healing open wounds: The 'right' topical insulin can expedite closure
May 1st 2008Researchers in the past have tried many different approaches to treating burn wounds and leg ulcers, including topical insulin, achieving mixed success. A recent study showed that the use of the right topical insulin could significantly speed up the wound healing process and wound closure.
Disseminated superficial actinic porokeratosis: Diclofenac sodium gel could provide treatment
May 1st 2008A small study shows that diclofenac sodium gel could provide an effective treatment for disseminated superficial actinic porokeratosis, although results so far suggest the drug may be better at preventing progression than clearing lesions, a study co-author says.
Bullous pemphigoid can masquerade as psoriasis
May 1st 2008Dermatologist Jean-Claude Bystryn, M.D., is used to seeing cases that most dermatologists consider rare, such as pemphigus, pemphigoid and superficial pemphigoid. But even Dr. Bystryn, professor of dermatology at New York University School of Medicine, was reminded recently that not everything is as it appears.
Treating rare cancers: Nontraditional therapies may work for unusual lesions
May 1st 2008When faced with unusual skin lesions, consult with colleagues, stay open to the possibility that a skin condition you are seeing may not be common and be open to trying innovative treatments, says James Spencer, M.D., of St. Petersburg, Fla.
Universal healthcare: Physician's support for national health insurance increasing
May 1st 2008Are physician attitudes toward a universal healthcare system changing? The results of a survey recently released by the University of Indiana (UI) and published in the Annals of Internal Medicine seem to indicate that may be the case.
Opinion: Heresy for dermatologists: An alternative view to mass skin cancer screenings
May 1st 2008Among the many advantages of being in private practice without ties to any particular establishment is that I can say just about anything without any concern for public ridicule or chastisement (private ridicule continues unabated).